{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,15]],"date-time":"2025-12-15T22:30:13Z","timestamp":1765837813388},"reference-count":25,"publisher":"Wiley","issue":"10","license":[{"start":{"date-parts":[[2012,9,20]],"date-time":"2012-09-20T00:00:00Z","timestamp":1348099200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Int J Dermatology"],"published-print":{"date-parts":[[2012,10]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>This study aimed to highlight the importance of routine screening for hyperglycemia and to develop a standardized, evidence\u2010based approach for the management of pemphigus patients on prolonged systemic corticosteroid (CS) therapy. A cross\u2010sectional study was conducted in two university\u2010affiliated teaching hospitals using a referred sample of 200 patients with a confirmed diagnosis of pemphigus vulgaris, pemphigus foliaceus, or mucous membrane pemphigoid. All patients were receiving systemic CS therapy. A total of 150 patients responded to the survey. Six participants were excluded and 144 were included. The main outcome measure was blood glucose level to detect hyperglycemia. New\u2010onset hyperglycemia was identified in 40% of patients who received CS therapy. None of the expected variables, including age, body mass index, family history of diabetes, corticosteroid dose, and duration of corticosteroid therapy, were independently associated with new\u2010onset hyperglycemia. These findings indicate that the prevalence of CS\u2010induced hyperglycemia in pemphigus patients is 40% and that in patients with pemphigus or MMP, CS therapy is associated with a markedly increased risk for hyperglycemia (odds ratio\u2003=\u200310.7, 95% confidence interval 1.38\u201383.50) compared with that of patients with the same diseases who do not receive CS therapy.<\/jats:p>","DOI":"10.1111\/j.1365-4632.2012.05470.x","type":"journal-article","created":{"date-parts":[[2012,9,21]],"date-time":"2012-09-21T01:55:23Z","timestamp":1348192523000},"page":"1248-1252","update-policy":"http:\/\/dx.doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Corticosteroid\u2010induced hyperglycemia is increased 10\u2010fold in patients with pemphigus"],"prefix":"10.1111","volume":"51","author":[{"given":"Afsaneh","family":"Alavi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julia","family":"Lowe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Scott","family":"Walsh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Juurlink","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Soroush","family":"Mortaz\u2010Hedjri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Neil H.","family":"Shear","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2012,9,20]]},"reference":[{"key":"e_1_2_5_2_2","unstructured":"KennethD KochanekMA SherryL et\u00a0al.National Vital Statistics Report 53.2004.http:\/\/www.cdc.gov\/nchs\/data\/nvsr\/nvsr53\/nvsr53_05acc.pdf. (Accessed October 25th 2010)."},{"key":"e_1_2_5_3_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1742-4801.2005.00085.x"},{"key":"e_1_2_5_4_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(09)60553-5"},{"key":"e_1_2_5_5_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00125-006-0570-3"},{"key":"e_1_2_5_6_2","doi-asserted-by":"publisher","DOI":"10.1001\/archderm.1996.03890260105016"},{"key":"e_1_2_5_7_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2008.01.012"},{"key":"e_1_2_5_8_2","doi-asserted-by":"publisher","DOI":"10.2310\/7750.2006.00053"},{"key":"e_1_2_5_9_2","doi-asserted-by":"publisher","DOI":"10.1093\/qjmed\/93.2.105"},{"key":"e_1_2_5_10_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2005.01.010"},{"key":"e_1_2_5_11_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0889-857X(05)70083-1"},{"key":"e_1_2_5_12_2","doi-asserted-by":"publisher","DOI":"10.1530\/eje.0.1460419"},{"key":"e_1_2_5_13_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1582-4934.2007.00033.x"},{"key":"e_1_2_5_14_2","unstructured":"Australian Longitudinal Study of Women\u2019s Health.Women health and ageing.http:\/\/www.alswh.org.au\/surveys.html. (Accessed October 25th 2010)."},{"key":"e_1_2_5_15_2","first-page":"39","article-title":"Canadian Diabetes Association 2008. Update on the Canadian Diabetes Association 2008 clinical practice guidelines","volume":"55","author":"Bhattacharyya OK","year":"2009","journal-title":"Can Fam Physician"},{"key":"e_1_2_5_16_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00125-009-1526-1"},{"key":"e_1_2_5_17_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.rmed.2009.01.003"},{"key":"e_1_2_5_18_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0190-9622(88)70128-0"},{"key":"e_1_2_5_19_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00198-008-0670-7"},{"key":"e_1_2_5_20_2","first-page":"127","volume-title":"Comprehensive Dermatologic Drug Therapies","author":"Wolverton SE","year":"2007"},{"key":"e_1_2_5_21_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1468-3083.2002.00504.x"},{"key":"e_1_2_5_22_2","doi-asserted-by":"publisher","DOI":"10.1097\/MAO.0b013e3181a52773"},{"key":"e_1_2_5_23_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra033540"},{"key":"e_1_2_5_24_2","doi-asserted-by":"publisher","DOI":"10.1592\/phco.24.5.508.33355"},{"key":"e_1_2_5_25_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0190-9622(84)70266-0"},{"key":"e_1_2_5_26_2","doi-asserted-by":"publisher","DOI":"10.4158\/EP08331.RAR"}],"container-title":["International Journal of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-4632.2012.05470.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1365-4632.2012.05470.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,15]],"date-time":"2023-10-15T04:15:11Z","timestamp":1697343311000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1365-4632.2012.05470.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,9,20]]},"references-count":25,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2012,10]]}},"alternative-id":["10.1111\/j.1365-4632.2012.05470.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1365-4632.2012.05470.x","archive":["Portico"],"relation":{},"ISSN":["0011-9059","1365-4632"],"issn-type":[{"value":"0011-9059","type":"print"},{"value":"1365-4632","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,9,20]]},"assertion":[{"value":"2012-09-20","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}